Results 201 to 210 of about 98,994 (359)

Merkel Cell Carcinoma With Divergent Differentiation—Or Something Else? A Triphasic Cutaneous Carcinoma With Lineage Plasticity

Journal of Cutaneous Pathology, EarlyView.
ABSTRACT Merkel cell carcinoma (MCC) is a rare, aggressive cutaneous neuroendocrine carcinoma that typically arises in sun‐exposed skin of older or immunosuppressed patients. Combined or collision tumors involving MCC and other cutaneous malignancies are uncommon, and tumors exhibiting more than two distinct malignant phenotypes are exceptionally rare.
Zeinab Khalil, Hozaifa Elameen, Ahmed K. Alomari   +2 more
wiley   +1 more source

Current Clinical Utility of Gene Expression Panels in Primary Cutaneous Melanoma. [PDF]

Cancers (Basel)
Garza TL, Choi JH, McGee M, Box E, Nywening T, Karachristos A, Schwarzberg A, Fishman M, Jacobson R.   +8 more
europepmc   +1 more source

Depicting the Immunological Landscape of Basal Cell Carcinoma Subtypes

Journal of Cutaneous Pathology, EarlyView.
ABSTRACT Background Anti‐PD‐1 response has been associated with higher PD‐1 ligand (PD‐L1) expression levels in different cancer types. Cemiplimab, an anti‐PD‐1 antibody, has been shown to induce a response rate of 31% and 22% in patients with locally advanced basal cell carcinoma (BCC) and metastatic BCC respectively, who have progressed or are ...
Isabella Dommann, Gaetana Restivo, Isabel Kolm, Federica Sella, Patrick Turko, Phil F. Cheng, Mitchell Levesque, Corina Dommann‐Scherrer, Reinhard Dummer, Egle Ramelyte   +9 more
wiley   +1 more source

Combined Immunotherapy and Hepatic Resection in Cutaneous Melanoma Liver Metastases. [PDF]

Cureus
Martins AL, Oliveira J, Ferreira A, Oliveira RC, Martins R.   +4 more
europepmc   +1 more source

Analysis of epidemiological, clinical and pathological factors and expression of OCT4 and NANOG proteins in cutaneous melanoma samples

, 2016
Constanza Thaise Xavier Silva
openalex   +1 more source

Figure S6 from Dual Covalent Inhibition of PKM and IMPDH Targets Metabolism in Cutaneous Metastatic Melanoma

, 2023
Marwa Zerhouni, Anthony R. Martin, Nathan Furstoss, Vincent S. Gutierrez, Emilie Jaune, Nedra Tekaya, Guillaume E. Béranger, Patricia Abbe, Claire Regazzetti, Hella Amdouni, Mohsine Driowya, Patrice Dubreuil, Frédéric Luciano, Arnaud Jacquel, Meri K. Tulić, Thomas Cluzeau, Brendan P. O’Hara, Issam Ben‐Sahra, Thierry Passeron, Rachid Benhida, Guillaume Robert, Patrick Auberger, Stéphane Rocchi   +22 more
openalex   +1 more source

Dermatologic Toxicities Associated With Novel Pan‐RAS/RAF Inhibitors

Journal of Cutaneous Pathology, EarlyView.
ABSTRACT Background The mitogen‐activated protein kinase (MAPK) pathway plays a key role in cell‐cycle regulation and tumor progression in cancer. Dermatologic toxicities (DTs) to newer pan‐RAS (RMC‐6236) and pan‐RAF (LXH254/naporafenib) inhibitors are emerging.
Lin J. He, Shaymaa Hegazy, Phyu P. Aung, Priyadharsini Nagarajan, Fiorinda Muhaj, Adrienne N. Choksi, Ana M. Ciurea, Kelly C. Nelson, Doina Ivan, Carlos A. Torres‐ Cabala, Victor G. Prieto, Jonathan L. Curry   +11 more
wiley   +1 more source

Adjuvant Therapy for High-Risk Stage II Cutaneous Melanoma: Insights and Future Directions. [PDF]

Cancers (Basel)
Pravisano F, Costa J, Marchi L, Pascoletti G, Poletto E, Del Vecchio M, Spagnoletti A, Cimminiello C, Papadopoulos N, Pigozzo J, Piccin L, Roccuzzo G, Fava P, Puglisi F, Aprile G, Minisini AM.   +15 more
europepmc   +1 more source

LINE-1 hypermethylation in peripheral blood of cutaneous melanoma patients is associated with metastasis

, 2015
Érica Sara Souza de Araújo, André Yoshiaki Kashiwabara, Maria Isabel Achatz, Luciana Facure Moredo, Bianca Costa Soares de Sá, João Pedreira Duprat Neto, Carla Rosenberg, Dirce Maria Carraro, Ana Cristina Victorino Krepischi   +8 more
openalex   +1 more source

Insights into the Transforming Growth Factor-β Signaling Pathway in Cutaneous Melanoma [PDF]

, 2013
Carole Y. Perrot, Delphine Javelaud, Alain Mauviel   +2 more
openalex   +1 more source